6
PYFA0306.TXT

PYFA
Pyridam Farma Tbk
Af          :
Sector Code : 53
Sector Name : PHARMACEUTICALS

(In thousand rupiah except Par Value, Closing Price and Ratios)

Financial Statement Date    : 30-Jun-2003
Fiscal Year Ends            : Dec
Months Covered in Income St : 6

Summary of Balance Sheet
  Receivables               :       4,702,183.16
  Inventories               :       6,163,465.69
  Current Assets            :      12,497,723.23
  Fixed Assets              :      56,575,877.02
  Other Asstes              :               0.00
  Total Assets              :      69,522,845.05
  Current Liabilities       :       6,214,921.02
  Longterm Liabiities       :       2,681,261.94
  Total Liabilities         :       8,896,182.96
  Authorized                :       1,600,000.00
  Paid-up Capital           :      53,508,000.00
  Par Value                 :                100
  Paid-up Capital Shares    :         535,080.00
  Retained Earnings         :       5,053,583.59
  Total Equity              :      60,626,662.09
  Minority Interest         :               0.00

Summary of Income Statement
  Total Sales               :      13,134,349.59
  Cost of Good Sold         :       4,725,587.69
  Gross Profit              :       8,408,761.90
  Operating Profit          :       1,108,992.52
  Other Income              :        -304,283.64
  Eearning Before Tax       :         804,708.88
  Tax                       :         270,493.30
  Net Income                :         534,215.59
  Closing Price             :             270.00

Per Share Data (Rp)
  Eps                       :               2.00
  Book Value                :             113.30

Financial Ratios
  Debt Equity Ratio (X)     :                .15
  Roa (%)                   :               1.54
  Roe (%)                   :               1.76
  Npm (%)                   :               8.13
  Opm (%)                   :              16.89

Cash Flow
  CF from Operating Activities                        :       4,178,724.64
  CF from Investing Activities                        :      -1,152,549.76
  CF from Financing Activities                        :      -3,066,549.28
  Net Increase in Cash & Cash Equivalent              :         -40,374.40
  Cash & Cash Equivalent at The Beginning of The Year :         831,256.76
  Cash & Cash Equivalent at The End of The Year       :         790,882.36

 
 
 
